BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 19815871)

  • 1. Adaptation of a Thai multidrug-resistant C2A clone of Plasmodium falciparum to Aotus monkeys and its preliminary in vivo antimalarial drug efficacy-resistance profile.
    Obaldía N; Milhous W; Kyle D
    Am J Trop Med Hyg; 2009 Oct; 81(4):587-94. PubMed ID: 19815871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adaptation of a multi-drug resistant strain of Plasmodium falciparum from Peru to Aotus lemurinus griseimembra, A. nancymaae, and A. vociferans monkeys.
    Collins WE; Sullivan JS; Hall P; Ruebush TK; Williams A; Grady KK; Bounngaseng A; Nace D; Williams T; Huber C; Galland GG; Barnwell JW; Sullivan JJ
    Am J Trop Med Hyg; 2007 Aug; 77(2):261-5. PubMed ID: 17690397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of atovaquone-proguanil for treatment of acute multidrug-resistant Plasmodium falciparum malaria in Thailand.
    Krudsood S; Patel SN; Tangpukdee N; Thanachartwet W; Leowattana W; Pornpininworakij K; Boggild AK; Looareesuwan S; Kain KC
    Am J Trop Med Hyg; 2007 Apr; 76(4):655-8. PubMed ID: 17426165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potentiation of antimalarial drug action by chlorpheniramine against multidrug-resistant Plasmodium falciparum in vitro.
    Nakornchai S; Konthiang P
    Parasitol Int; 2006 Sep; 55(3):195-9. PubMed ID: 16750932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluoxetine potentiates chloroquine and mefloquine effect on multidrug-resistant Plasmodium falciparum in vitro.
    Khairul MF; Min TH; Low JH; Nasriyyah CH; A'shikin AN; Norazmi MN; Ravichandran M; Raju SS
    Jpn J Infect Dis; 2006 Oct; 59(5):329-31. PubMed ID: 17060702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced activity of mefloquine and artesunic acid against Plasmodium falciparum in vitro and P. berghei in mice by combination with ciprofloxacin.
    Andrade AA; de Pilla Varotti F; de Freitas IO; de Souza MV; Vasconcelos TR; Boechat N; Krettli AU
    Eur J Pharmacol; 2007 Mar; 558(1-3):194-8. PubMed ID: 17214980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of azithromycin or erythromycin in combination with antimalarial drugs against multidrug-resistant Plasmodium falciparum in vitro.
    Nakornchai S; Konthiang P
    Acta Trop; 2006 Dec; 100(3):185-91. PubMed ID: 17126280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adaptation of a strain of Plasmodium falciparum from a Montagnard refugee to Aotus monkeys.
    Collins WE; Grady KK; Millet P; Sullivan JS; Morris CL; Galland GG; Richardson BB; Yang C
    J Parasitol; 1997 Dec; 83(6):1174-7. PubMed ID: 9406798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimalarial efficacy and drug interactions of the novel semi-synthetic endoperoxide artemisone in vitro and in vivo.
    Vivas L; Rattray L; Stewart LB; Robinson BL; Fugmann B; Haynes RK; Peters W; Croft SL
    J Antimicrob Chemother; 2007 Apr; 59(4):658-65. PubMed ID: 17337512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roxithromycin potentiates the effects of chloroquine and mefloquine on multidrug-resistant Plasmodium falciparum in vitro.
    Min TH; Khairul MF; Low JH; Che Nasriyyah CH; A'shikin AN; Norazmi MN; Ravichandran M; Raju SS
    Exp Parasitol; 2007 Apr; 115(4):387-92. PubMed ID: 17118354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effective treatment of uncomplicated Plasmodium falciparum malaria with azithromycin-quinine combinations: a randomized, dose-ranging study.
    Miller RS; Wongsrichanalai C; Buathong N; McDaniel P; Walsh DS; Knirsch C; Ohrt C
    Am J Trop Med Hyg; 2006 Mar; 74(3):401-6. PubMed ID: 16525097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasmodium falciparum in vivo resistance to quinine: description of two RIII responses in French Guiana.
    Demar M; Carme B
    Am J Trop Med Hyg; 2004 Feb; 70(2):125-7. PubMed ID: 14993621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimalarial pharmacodynamics and pharmacokinetics of a third-generation antifolate--JPC2056--in cynomolgus monkeys using an in vivo in vitro model.
    Edstein MD; Kotecka BM; Ager AL; Smith KS; DiTusa CA; Diaz DS; Kyle DE; Schiehser GA; Jacobus DP; Rieckmann KH; O'Neil MT
    J Antimicrob Chemother; 2007 Oct; 60(4):811-8. PubMed ID: 17646199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of monthly tafenoquine for prophylaxis of Plasmodium vivax and multidrug-resistant P. falciparum malaria.
    Walsh DS; Eamsila C; Sasiprapha T; Sangkharomya S; Khaewsathien P; Supakalin P; Tang DB; Jarasrumgsichol P; Cherdchu C; Edstein MD; Rieckmann KH; Brewer TG
    J Infect Dis; 2004 Oct; 190(8):1456-63. PubMed ID: 15378438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered drug susceptibility during host adaptation of a Plasmodium falciparum strain in a non-human primate model.
    Obaldía N; Dow GS; Gerena L; Kyle D; Otero W; Mantel PY; Baro N; Daniels R; Mukherjee A; Childs LM; Buckee C; Duraisingh MT; Volkman SK; Wirth DF; Marti M
    Sci Rep; 2016 Feb; 6():21216. PubMed ID: 26880111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of peroxisome proliferator-activated receptor gamma agonists as adjunctive treatment for Plasmodium falciparum malaria: a randomized, double-blind, placebo-controlled trial.
    Boggild AK; Krudsood S; Patel SN; Serghides L; Tangpukdee N; Katz K; Wilairatana P; Liles WC; Looareesuwan S; Kain KC
    Clin Infect Dis; 2009 Sep; 49(6):841-9. PubMed ID: 19673614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimalarial drug susceptibility and point mutations associated with drug resistance in 248 Plasmodium falciparum isolates imported from Comoros to Marseille, France in 2004 2006.
    Parola P; Pradines B; Simon F; Carlotti MP; Minodier P; Ranjeva MP; Badiaga S; Bertaux L; Delmont J; Morillon M; Silai R; Brouqui P; Parzy D
    Am J Trop Med Hyg; 2007 Sep; 77(3):431-7. PubMed ID: 17827355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Artemisinin derivatives and malaria: useful, in combination with other antimalarials.
    Prescrire Int; 2008 Aug; 17(96):162-8. PubMed ID: 19492494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atovaquone-proguanil resistance in imported falciparum malaria in a young child.
    Rose GW; Suh KN; Kain KC; Le Saux N; McCarthy AE
    Pediatr Infect Dis J; 2008 Jun; 27(6):567-9. PubMed ID: 18434932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The A/T-specific DNA alkylating agent adozelesin inhibits Plasmodium falciparum growth in vitro and protects mice against Plasmodium chabaudi adami infection.
    Yanow SK; Purcell LA; Spithill TW
    Mol Biochem Parasitol; 2006 Jul; 148(1):52-9. PubMed ID: 16597469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.